These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 3798928)

  • 1. [Hypercholesterolemia in patients with hypertension and diabetes mellitus. The need for cholesterol control in the prevention of ischemic heart disease].
    Heyden S
    Wien Med Wochenschr; 1986 Sep; 136(17):437-42. PubMed ID: 3798928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of myocardial infarction attributable to elevated levels of total cholesterol among hypertensives.
    Glazer NL; Smith NL; Heckbert SR; Doggen CJ; Lemaitre RN; Psaty BM
    Am J Hypertens; 2005 Jun; 18(6):759-66. PubMed ID: 15925732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of plasma hormones and lipids in healthy elderly Thais compared to patients with chronic diseases: diabetes mellitus, essential hypertension and coronary heart disease.
    Chearskul S; Charoenlarp K; Thongtang V; Nitiyanant W
    J Med Assoc Thai; 2000 Mar; 83(3):266-77. PubMed ID: 10808681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Major nutrition-related risk factors of ischemic heart disease: dyslipoproteinemia, obesity, hypertension, glucose intolerance].
    Pados G
    Orv Hetil; 1999 Jul; 140(28):1563-72. PubMed ID: 10443132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy and prevention of coronary heart diseases through lowering of the serum cholesterol levels; third consensus 'Cholesterol'. Consensus Working Group, CBO].
    Simoons ML; Casparie AF
    Ned Tijdschr Geneeskd; 1998 Sep; 142(38):2096-101. PubMed ID: 9856223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New treatment guidelines for a patient with diabetes and hypertension.
    Mogensen CE
    J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of coronary heart disease through cholesterol reduction.
    Grundy SM
    Am Fam Physician; 1997 May; 55(6):2250-8. PubMed ID: 9149652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should cholesterol be measured in all hypertensives?
    Haq IU; Yeo WW; Jackson PR; Ramsay LE
    J Hum Hypertens; 1995 Jun; 9(6):417-21. PubMed ID: 7473521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypertension management in general practice in Iceland].
    Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
    Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
    Marchioli R; Marfisi RM; Carinci F; Tognoni G
    Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
    Ravindran R; Krishnan LK
    Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician strategies for the prevention of coronary heart disease.
    Margolis S
    Johns Hopkins Med J; 1977 Sep; 141(3):170-6. PubMed ID: 330915
    [No Abstract]   [Full Text] [Related]  

  • 15. The need for tighter control of cardiovascular risk factors in diabetic patients.
    Viberti G
    J Hypertens Suppl; 2003 Mar; 21(1):S3-6. PubMed ID: 12769160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk factors for ischemic heart disease in Mexico: a case control study].
    Camacho-Hernández R; Corona-Muñiz I; Vázquez-Martínez JL; Martínez-Rodríguez F; Escobedo-de la Peña J
    Arch Inst Cardiol Mex; 1995; 65(4):315-22. PubMed ID: 8561652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease.
    Tenenbaum A; Motro M; Fisman EZ; Schwammenthal E; Adler Y; Goldenberg I; Leor J; Boyko V; Mandelzweig L; Behar S
    Circulation; 2004 May; 109(18):2197-202. PubMed ID: 15123532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary flow reserve in hypertensive patients with hypercholesterolemia and without coronary heart disease.
    Galderisi M; de Simone G; Cicala S; Parisi M; D'Errico A; Innelli P; de Divitiis M; Mondillo S; de Divitiis O
    Am J Hypertens; 2007 Feb; 20(2):177-83. PubMed ID: 17261464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
    Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
    J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatable risk factors--hypercholesterolemia, smoking, and hypertension--after myocardial infarction: implications of the coronary drug project data for clinical management. Coronary Drug Project Research Group.
    Prim Care; 1980 Mar; 7(1):175-9. PubMed ID: 6992178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.